Advances in autosomal dominant polycystic kidney disease-2014 and beyond.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25183846.
- Also identified by DOI 10.3949/ccjm.81gr.14001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD), which frequently leads to end-stage renal disease, currently has no specific drug therapies. Better understanding of its pathogenesis and recent clinical trials have led to more accurate diagnosis of the disease and its manifestations, as well as to promising new approaches to treatment.
Medical subject headings
- Polycystic Kidney, Autosomal Dominant
- Vasopressins